CHRIS AMOS to Exons
This is a "connection" page, showing publications CHRIS AMOS has written about Exons.
Connection Strength
0.499
-
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs). Mutat Res. 2004 Oct 04; 554(1-2):175-83.
Score: 0.183
-
Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003 Nov; 73(5):1157-61.
Score: 0.171
-
Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
Score: 0.045
-
The Pitfalls of Companion Diagnostics: Evaluation of Discordant EGFR Mutation Results from a Clinical Laboratory and a Central Laboratory. J Mol Diagn. 2016 05; 18(3):331-335.
Score: 0.025
-
RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq. PLoS One. 2015; 10(9):e0136653.
Score: 0.024
-
Genes with a large intronic burden show greater evolutionary conservation on the protein level. BMC Evol Biol. 2014 Mar 16; 14(1):50.
Score: 0.022
-
Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet. 2003 Apr; 72(4):975-83.
Score: 0.010
-
Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot. Am J Hum Genet. 2002 May; 70(5):1357-62.
Score: 0.010
-
The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8.
Score: 0.009